NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
TMS Therapy for Post-Traumatic Stress Disorder (PTSD): A New Hope
Post-Traumatic Stress Disorder (PTSD) can profoundly affect an individual’s life, leading to symptoms such as flashbacks, severe anxiety, and emotional [...]
Unlocking New Potential: TMS Therapy for Attention Deficit Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder (ADHD) can impact many areas of life, including concentration, impulse control, and organization. While traditional treatments [...]
TMS Therapy for Fibromyalgia: A New Approach to Managing Chronic Pain
Fibromyalgia is a chronic condition characterized by widespread pain, fatigue, and tender points throughout the body. Traditional treatments often involve [...]
TMS Therapy for Autism: Enhancing Neurodevelopmental Outcomes
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by challenges in communication, social interaction, and repetitive behaviors. Traditional [...]
How Yoga Boosts Your Brain: The Mind-Body Connection
Namaste! Yoga is well known for promoting relaxation and flexibility, but did you know it also supercharges your brain? Those [...]
TMS Therapy: A Breakthrough in Pain Management
Chronic pain is a complex condition that can be life-altering, affecting everything from your physical abilities to your emotional well-being. [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social